The typical case for the fund is to invest in rounds with 5 participants. Despite the KLP Ventures, startups are often financed by MassDevelopment. The meaningful sponsors for the fund in investment in the same round are RKS Ventures, Material Impact Fund, LaunchCapital. In the next rounds fund is usually obtained by RKS Ventures, Material Impact Fund, LaunchCapital.
The high activity for fund was in 2017. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is generally included in less than 2 deals every year.
Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular fund investment industries, there are Market Research, Information Technology. Among the most popular portfolio startups of the fund, we may highlight Amastan Technologies.
|Banner Health||Arizona, Phoenix, United States|
|Broadsword Partners||New York, New York, United States|
|DBS Bank||Central, Central Region, Singapore|
|ISA Ventures||Cedar Rapids, Iowa, United States|
|Kuai CTO||China, Shanghai|
|Neuberger Berman Group||New York, New York, United States|
|Pittsburgh Life Sciences Greenhouse||Pennsylvania, Pittsburgh, United States|
|Seraph Group||California, Foster City, United States|
|$13M||26 Oct 2017||Massachusetts, United States|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.